BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8589480)

  • 1. Treatment of erythropoietic protoporphyria with hydroxyethylrutosides.
    Schoemaker JH; Bousema MT; Zijlstra H; van der Horst FA
    Dermatology; 1995; 191(1):36-8. PubMed ID: 8589480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of erythropoietic protoporphyria with cysteine.
    Mathews-Roth MM; Rosner B
    Photodermatol Photoimmunol Photomed; 2002 Dec; 18(6):307-9. PubMed ID: 12535027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular changes in erythropoietic protoporphyria: histopathologic and immunohistochemical study.
    Timonen K; Kariniemi AL; Niemi KM; Teppo AM; Tenhunen R; Kauppinen R
    J Am Acad Dermatol; 2000 Sep; 43(3):489-97. PubMed ID: 10954661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of cysteine photoprotection in erythropoietic protoporphyria.
    Mathews-Roth MM; Rosner B; Benfell K; Roberts JE
    Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):244-8. PubMed ID: 7727280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototesting in erythropoietic protoporphyria trials: A systematic review.
    Heerfordt IM; Philipsen PA; Lerche CM; Wulf HC
    Exp Dermatol; 2023 Jul; 32(7):1042-1047. PubMed ID: 37052136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria.
    Boffa MJ; Ead RD; Reed P; Weinkove C
    Photodermatol Photoimmunol Photomed; 1996 Feb; 12(1):27-30. PubMed ID: 8884896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent painful hand crisis in a four-year-old girl, revealing an erythropoietic protoporphyria.
    Labrousse AL; Salmon-Ehr V; Eschard C; Kalis B; Leonard F; Bernard P
    Eur J Dermatol; 1998; 8(7):515-6. PubMed ID: 9854167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements.
    Raef HS; Rebeiz L; Leaf RK; Hughes O; Jiang P; ElSeht A; Anderson KE; Wheeden K; Kochevar I; Elmariah SB; Dickey AK
    JAMA Dermatol; 2023 Feb; 159(2):204-208. PubMed ID: 36630131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
    Mathews-Roth MM; Pathak MA; Fitzpatrick TB; Harber LH; Kass EH
    Arch Dermatol; 1977 Sep; 113(9):1229-32. PubMed ID: 900968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protoporphyrin photosensitivity cannot be attenuated by oral N-acetylcysteine.
    Bijlmer-Iest JC; Baart de la Faille H; van Asbeck BS; van Hattum J; van Weelden H; Marx JJ; Koningsberger JC
    Photodermatol Photoimmunol Photomed; 1992-1993 Dec; 9(6):245-9. PubMed ID: 1343225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable effects of beta-carotene therapy in a child with erythropoietic protoporphyria.
    Alemzadeh R; Feehan T
    Eur J Pediatr; 2004 Sep; 163(9):547-9. PubMed ID: 15241683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymorphic light dermatitis. Photobiology and photoprotection].
    Corrales Padilla H
    Med Cutan Ibero Lat Am; 1976; 4(1):45-52. PubMed ID: 988444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against visible light by dihydroxyacetone in erythropoietic protoporphyria.
    Heerfordt IM; Philipsen PA; Lerche CM; Wulf HC
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103302. PubMed ID: 36690194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
    Lim HW
    Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietic protoporphyria: treatment with antioxidants and potential cure with gene therapy.
    Mathews-Roth MM
    Methods Enzymol; 2000; 319():479-84. PubMed ID: 10907535
    [No Abstract]   [Full Text] [Related]  

  • 16. An explorative study of non-invasive ultra-weak photon emission and the anti-oxidative influence of oral zinc sulphate in light-sensitive patients with erythropoietic protoporphyria.
    Petersen AB; Philipsen PA; Wulf HC
    Skin Res Technol; 2012 Nov; 18(4):405-12. PubMed ID: 22092997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human protoporphyria: reduced cutaneous photosensitivity and lower erythrocyte porphyrin levels during pregnancy.
    Poh-Fitzpatrick MB
    J Am Acad Dermatol; 1997 Jan; 36(1):40-3. PubMed ID: 8996259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of erythropoietic protoporphyria.
    Mathews-Roth MM
    Semin Liver Dis; 1998; 18(4):425-6. PubMed ID: 9875559
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone.
    Harms JH; Lautenschlager S; Minder CE; Minder EI
    Photochem Photobiol; 2009; 85(6):1434-9. PubMed ID: 19656325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dersimelagon in Erythropoietic Protoporphyrias.
    Balwani M; Bonkovsky HL; Levy C; Anderson KE; Bissell DM; Parker C; Takahashi F; Desnick RJ; Belongie K;
    N Engl J Med; 2023 Apr; 388(15):1376-1385. PubMed ID: 37043653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.